HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Aikata Selected Research

hepatitis B surface antigen presurface protein 1

1/2021Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Aikata Research Topics

Disease

120Hepatocellular Carcinoma (Hepatoma)
06/2022 - 09/2002
50Neoplasms (Cancer)
10/2021 - 01/2007
44Infections
02/2022 - 04/2009
29Chronic Hepatitis C
01/2021 - 01/2007
26Neoplasm Metastasis (Metastasis)
10/2021 - 01/2007
25Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 10/2007
21Fibrosis (Cirrhosis)
07/2022 - 10/2007
19Thrombosis (Thrombus)
10/2021 - 10/2007
12Non-alcoholic Fatty Liver Disease
01/2022 - 03/2014
12Chronic Hepatitis B
01/2021 - 08/2010
12Hepatitis C
09/2020 - 06/2007
10Liver Diseases (Liver Disease)
03/2022 - 11/2011
9Esophageal and Gastric Varices (Esophageal Varices)
01/2021 - 01/2008
8Portal Hypertension
08/2021 - 01/2008
8Hepatic Encephalopathy
11/2020 - 03/2011
7Hepatitis B
01/2021 - 03/2015
7Hepatitis
01/2021 - 08/2008
6Liver Neoplasms (Liver Cancer)
01/2021 - 05/2009
6Disease Progression
04/2020 - 12/2010
4Hemorrhage
01/2021 - 01/2008
4Chronic Hepatitis (Chronic Active Hepatitis)
12/2020 - 03/2017
4Edema (Dropsy)
02/2020 - 08/2016
4Type 2 Diabetes Mellitus (MODY)
01/2018 - 03/2014
4Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
05/2017 - 08/2012
3Pancreatitis
08/2022 - 10/2014
3Insulin Resistance
03/2022 - 12/2014
3Cholangiocarcinoma
01/2022 - 05/2009
3Lymphatic Metastasis
01/2022 - 08/2012
3Carcinogenesis
08/2021 - 01/2016
3Liver Failure
02/2021 - 01/2008
3Varicose Veins (Varicose Vein)
11/2020 - 05/2002
3Brain Diseases (Brain Disorder)
08/2019 - 03/2013
3Acute Liver Failure (Fulminant Hepatic Failure)
12/2017 - 08/2014
3Anemia
06/2017 - 05/2013
3Carcinoma (Carcinomatosis)
06/2015 - 07/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2022 - 02/2021
2Glucose Intolerance
03/2022 - 02/2017

Drug/Important Bio-Agent (IBA)

41InterferonsIBA
01/2021 - 10/2007
28Sorafenib (BAY 43-9006)FDA Link
05/2021 - 01/2012
23Antiviral Agents (Antivirals)IBA
02/2022 - 05/2012
21Ribavirin (Virazole)FDA LinkGeneric
12/2020 - 01/2007
18lenvatinibIBA
04/2022 - 01/2019
14daclatasvirIBA
01/2020 - 01/2014
13asunaprevirIBA
01/2020 - 01/2015
10Cisplatin (Platino)FDA LinkGeneric
06/2022 - 09/2002
10Fluorouracil (Carac)FDA LinkGeneric
12/2018 - 10/2007
9Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
8Pharmaceutical PreparationsIBA
01/2022 - 01/2008
8AntigensIBA
01/2021 - 10/2015
8RNA (Ribonucleic Acid)IBA
03/2020 - 06/2008
7Capsules (Microcapsules)IBA
07/2022 - 05/2013
7Glucose (Dextrose)FDA LinkGeneric
03/2022 - 03/2014
7DNA (Deoxyribonucleic Acid)IBA
11/2021 - 09/2015
7Hepatitis B Surface Antigens (HBsAg)FDA Link
08/2021 - 01/2017
6SofosbuvirIBA
12/2020 - 04/2017
6Interferon-alpha (Interferon Alfa)IBA
04/2009 - 01/2007
5Hemoglobins (Hemoglobin)IBA
03/2022 - 05/2015
5Alanine Transaminase (SGPT)IBA
01/2021 - 03/2014
5Proteins (Proteins, Gene)FDA Link
11/2020 - 07/2016
5NucleotidesIBA
10/2019 - 01/2017
5telaprevirIBA
06/2016 - 10/2014
5Ethiodized Oil (Ethiodol)FDA Link
07/2013 - 09/2002
4Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 04/2015
4EnzymesIBA
02/2021 - 06/2008
4regorafenibIBA
01/2021 - 09/2018
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 12/2014
4Immunoglobulins (Immunoglobulin)IBA
01/2021 - 10/2015
4Fetal Proteins (Fetoprotein)IBA
11/2020 - 01/2012
4ChemokinesIBA
03/2020 - 01/2016
4CytokinesIBA
01/2020 - 01/2016
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
05/2017 - 08/2012
4SimeprevirIBA
03/2017 - 06/2016
3pembrolizumabIBA
08/2022 - 07/2020
3Bevacizumab (Avastin)FDA Link
04/2022 - 08/2021
3atezolizumabIBA
04/2022 - 08/2021
3Circulating Tumor DNAIBA
06/2021 - 09/2015
3Immunoglobulin G (IgG)IBA
01/2021 - 06/2008
3Prothrombin (Factor II)IBA
01/2021 - 12/2014
3ChromatinIBA
01/2021 - 05/2018
3Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2020
3Protease Inhibitors (Protease Inhibitor)IBA
04/2020 - 11/2014
3AmmoniaIBA
08/2019 - 12/2018
3NucleosidesIBA
01/2019 - 01/2018
3ledipasvirIBA
12/2018 - 04/2017
3Zoledronic Acid (Zometa)FDA Link
09/2017 - 12/2010
3Hyaluronic Acid (Hyaluronan)IBA
07/2016 - 01/2016
3MicroRNAs (MicroRNA)IBA
03/2015 - 01/2012
3SuspensionsIBA
08/2010 - 09/2002
2Blood Glucose (Blood Sugar)IBA
03/2022 - 01/2018

Therapy/Procedure

86Therapeutics
06/2022 - 01/2007
30Drug Therapy (Chemotherapy)
06/2022 - 04/2008
17Liver Transplantation
01/2021 - 06/2007
16Radiotherapy
10/2021 - 12/2010
12Hepatectomy
01/2022 - 08/2012
6Surgical Portasystemic Shunt (Portosystemic Shunt)
08/2019 - 03/2011
5Radiofrequency Ablation
01/2020 - 03/2010
4Splenectomy
08/2021 - 06/2007
4Sclerotherapy
01/2021 - 01/2009
3Conformal Radiotherapy
06/2015 - 01/2009
2Glycemic Control
03/2022 - 03/2014